FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

2.

Single-dose radiation before surgery can eradicate breast cancer

3.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

4.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

5.

Regular physical activity before cancer diagnosis may lower progression and death risks


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot